Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Protara Therapeutics, Inc.
Market Cap
$143.60M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$143.84M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$143.10M
Operating Margin
-827.76%
TTM Avg
-1064.28%
3Y Avg
-1054.91%
5Y Avg
-3927.73%
Market Cap
$146.27M
Operating Margin
-111.00%
TTM Avg
-151.19%
3Y Avg
-184.89%
5Y Avg
-203.40%
Market Cap
$146.28M
Operating Margin
-54.46%
TTM Avg
-76.53%
3Y Avg
-68.82%
5Y Avg
-55.26%
Market Cap
$146.62M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-91.83%
Market Cap
$139.84M
Operating Margin
-102.41%
TTM Avg
-243.38%
3Y Avg
-183.77%
5Y Avg
-176.77%
Market Cap
$139.47M
Operating Margin
-221.72%
TTM Avg
-110.86%
3Y Avg
-55.43%
5Y Avg
-36.95%
Market Cap
$139.04M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-4081.44%
5Y Avg
-3115.66%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | $143.60M | 0.00% | 0.00% | 0.00% | 0.00% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $143.84M | 0.00% | 0.00% | 0.00% | 0.00% |
| Nyxoah S.A. (NYXH)vs › | $143.10M | -827.76% | -1064.28% | -1054.91% | -3927.73% |
| Fortress Biotech, Inc. (FBIOP)vs › | $146.27M | -111.00% | -151.19% | -184.89% | -203.40% |
| Codexis, Inc. (CDXS)vs › | $146.28M | -54.46% | -76.53% | -68.82% | -55.26% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.62M | 0.00% | 0.00% | 0.00% | -91.83% |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | -102.41% | -243.38% | -183.77% | -176.77% |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | -221.72% | -110.86% | -55.43% | -36.95% |
| Immuneering Corporation (IMRX)vs › | $139.04M | 0.00% | 0.00% | -4081.44% | -3115.66% |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 4.55% |
